Severe Agranulocytosis following Simultaneous Administration of Chlorpromazine and Trimethoprim-Sulfamethoxazole in a Patient with Sepsis: A Possible Toxic Combination
Background. Chlorpromazine and trimethoprim-sulfamethoxazole (TMP/SMX) are two commonly prescribed medications by physicians. Either of those medications could cause fatal drug-induced agranulocytosis, with an unclear underlying mechanism. The likelihood of simultaneous prescription of both medicati...
Main Authors: | Anil Jha, Hassan Ghoz, Nicholas James |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/5653497 |
Similar Items
-
Biofilm formation in trimethoprim/sulfamethoxazole-susceptible and trimethoprim/sulfamethoxazole-resistant uropathogenic Escherichia coli
by: Nitis Smanthong, et al.
Published: (2015-06-01) -
"Estimation of trimethoprim and sulfamethoxazole levels in tears after systemic administration"
by: Sharma G, et al.
Published: (1983-01-01) -
Evaluation of Sulfamethoxazole Concentrations in Treatment with High-Dose Trimethoprim/Sulfamethoxazole
by: Nguyen, Long, et al.
Published: (2013) -
Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole
by: G. Kouklakis;, et al.
Published: (2007-01-01) -
RP-LC method for simultaneous determination of sulfamethoxazole and trimethoprim content in veterinary drugs
by: Gabriela Padovani Tahan, et al.
Published: (2018-04-01)